Tranzactioneaza Immunocore Holdings plc (US.IMCR) - 36.03 USD (%) Tranzactioneaza
1D
1W
1M
3M
6M
1Y
5Y
Max
Indici
Descriere companie
Immunocore Holdings plc, formerly Immunocore Holdings Ltd, (http://www.immunocore.com/) is a late-stage biotechnology company. The Company is engaged in the development of TCR bispecific immunotherapies called Immune mobilizing monoclonal TCRs Against X disease (ImmTAX) designed to treat diseases, including cancer, infectious and autoimmune. The Company is developing a deep pipeline in multiple therapeutic areas, including five clinical stage programs in oncology and infectious disease, advanced pre-clinical programs in autoimmune disease and multiple earlier pre-clinical programs. The Company’s pipeline is leveraging ImmTAX platform within three therapeutic areas: oncology, infectious disease and autoimmune disease.